Main description:

Inorganic biomaterials possess unique properties which traditionally make them ideal for use in medical implants; however, these same properties also bring advantages in drug delivery applications, such as bioactivity, controllable porosity and solubility, high mechanical strength and biocompatibility. Inorganic Biomaterials for Drug Delivery covers a wide range of inorganic biomaterial types and their properties, from traditional materials like ceramics, metallics, and bioglasses, to novel composites and nano-engineered inorganic biomaterials. Biocompatibility, toxicity and regulatory considerations are also thoroughly discussed, ensuring the reader is fully equipped for efficient biomaterials selection and utilization in drug delivery applications.

Inorganic Biomaterials for Drug Delivery is a must-have reference for those working in the fields of materials science, biomedical engineering, pharmaceutical science and pharmacology, chemical engineering and clinical science.

Contents:

1. Introduction to inorganic biomaterials
2. Carbon nanotubes in drug delivery
3. Graphene and graphene oxide in drug delivery
4. Carbon dots in drug delivery
5. Gold nanoparticles in drug delivery
6. Silver nanoparticles in drug delivery
7. Iron nanoparticles in drug delivery
8. Use of platinum in drug delivery
9. Metal oxides in drug delivery
10. Use of titanium dioxide in drug delivery
11. Iron oxides in drug delivery
12. Calcium phosphates for drug delivery applications
13. Use of hydroxyapatite for drug delivery applications
14. Tricalcium phosphates in drug delivery
15. Calcium sulfate used in drug delivery
16. Nanophase ceramics-based systems used in drug delivery
17. Bioglass ceramics-based drug delivery systems
18. Mesoporous silica in drug delivery
19. Use of colloidal silica in drug delivery
20. Montmorillonite?in drug delivery
21. Kaolinite in drug delivery
22. Halloysite in drug delivery
23. Biocompatibility of synthetic biopolymers for drug delivery
24. Regulatory considerations of synthetic biopolymers for drug delivery
25. Challenges and future perspectives of inorganic biomaterials in drug delivery